Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
20°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alx Oncology Holdings Inc
(NQ:
ALXO
)
7.840
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
7.840
Bid (Size)
6.810 (4)
Ask (Size)
8.380 (3)
Prev. Close
7.840
Today's Range
7.840 - 7.840
52wk Range
3.936 - 12.33
Shares Outstanding
40,869,135
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Latest Analyst Ratings for ALX Oncology Holdings
November 14, 2023
Via
Benzinga
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023
From
ALX Oncology
Via
GlobeNewswire
Performance
YTD
-30.00%
-30.00%
1 Month
+8.89%
+8.89%
3 Month
+84.04%
+84.04%
6 Month
+6.23%
+6.23%
1 Year
-29.37%
-29.37%
More News
Read More
ALX Oncology Announces November Investor Conference Participation
November 01, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 10, 2023
From
ALX Oncology
Via
GlobeNewswire
The Latest Analyst Ratings for ALX Oncology Holdings
October 04, 2023
Via
Benzinga
Why ALX Oncology Stock Is Skyrocketing Today
October 03, 2023
Via
The Motley Fool
What's Going On With ALX Oncology Stock?
October 05, 2023
Via
Benzinga
ALX Oncology Announces Pricing of Public Offering
October 05, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Proposed Public Offering
October 04, 2023
From
ALX Oncology
Via
GlobeNewswire
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 04, 2023
Via
Benzinga
Cal-Maine Foods, A10 Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 04, 2023
Via
Benzinga
Crude Oil Moves Higher; POINT Biopharma Global Shares Jump
October 03, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 03, 2023
Via
Benzinga
ALX Oncology Holdings Inc. (NASDAQ: ALXO) is One of Tuesday Morning’s Most Active Stocks
October 03, 2023
Via
Investor Brand Network
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
October 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 03, 2023
Via
Benzinga
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
October 03, 2023
Via
Benzinga
Why Delta Apparel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 03, 2023
Via
Benzinga
S&P 500, Nasdaq Futures Waver As Focus Turns To JOLTS Data: Why These Analysts Say Expecting A Strong Q4 This Year Is 'Tricky'
October 03, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
October 03, 2023
From
ALX Oncology
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
October 02, 2023
Via
Benzinga
ALX Oncology to Host Investor Call and Webcast on October 3, 2023 to Share Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
October 02, 2023
From
ALX Oncology
Via
GlobeNewswire
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
Via
Investor Brand Network
Exposures
Product Safety
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
Via
FinancialNewsMedia
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.